Search - tctmd.com

Displaying 321 - 340 of 390

Sort: Relevancy | Date

Transcatheter Aortic Valve Implantation with Edwards SAPIEN™ versus Medtronic CoreValve Revalving System® Devices: a Multi-Center Collaborative Study The PRAGMATIC Initiative –...

Presentation TCT 2013

Transcatheter Aortic Valve Implantation with Edwards SAPIEN™ versus Medtronic CoreValve Revalving System® Devices: a Multi-Center Collaborative Study The PRAGMATIC Initiative –...

Presenter: Alaide Chieffo, Gill Buchanan, Nicolas Van Mieghem, Azeem Latib, Didier Tchetche, Nicolas DUMONTEIL, Robert M A Van Der Boon, Olivier Vahdat, Bertrand Marcheix, Patrick Serruys, Didier Carri?, Jean Fajadet, Peter De Jaegere, Ottavio Alfieri, Antonio Colombo

January 31, 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavo...

Presentation TCT 2013

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavo...

Presenter: Stefan Verheye, Christophe Dubois, Karl-Eugen Hauptmann, John Ormiston, James Stewart, Joachim Schofer, Karl Stangl, Bernhard Witzenbichler, Emanuele Barbato, Peter Fitzgerald, Hiromasa Otake, Patrick Serruys

January 31, 2013

Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From...

Presentation TCT 2013

Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From...

Presenter: Laura Mauri, Gabriel Steg, Alexis Matteau, Edoardo Camenzind, Eric Boersma, Pascal Vranckx, Patrick Serruys, William O'Neill, Robert Yeh, William Wijns

January 31, 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presentation TCT 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presenter: Nicolas DUMONTEIL, Alaide Chieffo, Didier Tchetche, Nicolas Van Mieghem, Bertrand Marcheix, Robert M A Van Der Boon, Gill Buchanan, Olivier Vahdat, Patrick Serruys, Jean Fajadet, Peter De Jaegere, Antonio Colombo, Didier Carri?

January 31, 2013

Frequency And Causes Of Stroke During Or After Transcatheter Aortic Valve Implantation

Presentation TCT 2013

Frequency And Causes Of Stroke During Or After Transcatheter Aortic Valve Implantation

Presenter: Rutger-Jan Nuis, Nicolas Van Mieghem, Carl Schultz, Adriaan Moelker, Robert M A Van Der Boon, Robert-Jan van Geuns, Aad van der Lugt, Patrick W. Serruys, Josep Rodes-Cabau, Ron Van Domburg, Peter Koudstaal, Peter De Jaegere

January 31, 2013

News Industry News

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

October 29, 2012

Bioabsorbable Drug-Eluting Scaffolds Are the Future! The Science Behind the Dream

Presentation TCT 2012

Bioabsorbable Drug-Eluting Scaffolds Are the Future! The Science Behind the Dream

Presenter: Patrick Serruys

October 26, 2012

LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents

Presentation TCT 2012

LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents

Presenter: Patrick Serruys

October 25, 2012

Left Main PCI vs. CABG Today: A Guide to Clinical Decision Making

Presentation TCT 2012

Left Main PCI vs. CABG Today: A Guide to Clinical Decision Making

Presenter: Patrick Serruys

October 24, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presentation TCT 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presenter: Patrick Serruys

October 23, 2012

TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up...

Presentation TCT 2012

TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up...

Presenter: Patrick Serruys

October 23, 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presentation TCT 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presenter: Patrick Serruys

October 23, 2012

Update from the Randomized SURTAVI Trial

Presentation TCT 2012

Update from the Randomized SURTAVI Trial

Presenter: Patrick Serruys

October 22, 2012

TAXUS: Final Five-Year SYNTAX Results (Entire Study Population)

Presentation TCT 2012

TAXUS: Final Five-Year SYNTAX Results (Entire Study Population)

Presenter: Patrick Serruys

October 22, 2012

BIOMATRIX: Final Five-Year LEADERS Results

Presentation TCT 2012

BIOMATRIX: Final Five-Year LEADERS Results

Presenter: Patrick Serruys

October 22, 2012

A Detailed Analysis of Stent Thrombosis from the SYNTAX Trial (All Patients and Left Main vs. Multivessel Disease Cohorts): Frequency, Timing, Vessel, and Contribution to...

Presentation TCT 2012

A Detailed Analysis of Stent Thrombosis from the SYNTAX Trial (All Patients and Left Main vs. Multivessel Disease Cohorts): Frequency, Timing, Vessel, and Contribution to...

Presenter: Patrick Serruys

October 22, 2012

News Conference News TCT 2012

SYNTAX: DES, CABG Comparable in Left Main Disease

October 22, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.